Cargando…

Updating existing QSAR models: selection and weighting of new data

Detalles Bibliográficos
Autores principales:	Öberg, Tomas, Liu, T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867151/ http://dx.doi.org/10.1186/1758-2946-2-S1-P19

Ejemplares similares

Comparison of applicability domains of QSAR models: application to the modelling of the environmental toxicity against Tetrahymena pyriformis
por: Tetko, Igor V, et al.
Publicado: (2008)

On some aspects of validation of predictive QSAR models
por: Roy, K, et al.
Publicado: (2008)

QSAR modelling of acute toxicity in the fathead minnow
por: Zakharov, Alexey, et al.
Publicado: (2008)

Automating QSAR expertise
por: Leahy, DE, et al.
Publicado: (2008)

Kernel-based estimation of the applicability domain of QSAR models
por: Fechner, Nikolas, et al.
Publicado: (2010)

A new software for fragment-based QSAR and its applications
por: Sosnin, Sergey B, et al.
Publicado: (2014)

QSAR of anti-inflammatory drugs
por: Khayrullina, Veronica R, et al.
Publicado: (2010)

Diagnostic of tautomer behaviour on QSAR models and AM1 optimisation
por: Thalheim, T, et al.
Publicado: (2011)

Reliable estimation of externally validated prediction errors for QSAR models
por: Baumann, Désirée, et al.
Publicado: (2013)

Surflex-QMOD: physically meaningful QSAR
por: Steudle, Alexander, et al.
Publicado: (2014)

QSPR designer – employ your own descriptors in the automated QSAR modeling process
por: Skřehota, Ondřej, et al.
Publicado: (2012)

QSAR modeling for In vitro assays: linking ToxCast™ database to the integrated modeling framework “OCHEM”
por: Abdelaziz, Ahmed, et al.
Publicado: (2012)

Sodium dependent glucose transporter (SGLT) 1 / 2 - elucidating inhibitor SAR and selectivity using homology modelling and 3D QSAR studies
por: Vorberg, Susann, et al.
Publicado: (2012)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Chemogenomic approach to increase accuracy of QSAR modeling of inhibition activity against five major P450 isoforms
por: Novotarskyi, Sergii, et al.
Publicado: (2013)

Prediction of highly-connected 'hub'-proteins in protein interaction networks using QSAR
por: Hsing, M, et al.
Publicado: (2010)

Analysis of naphthoquinone derivatives as topoisomerase I inhibitors using fragment based QSAR
por: Virupaksha, Bastikar, et al.
Publicado: (2013)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

Docking based 3D-QSAR studies applied at the BRAF inhibitors to understand the binding mechanism
por: Mahmood, Uzma, et al.
Publicado: (2012)

Building QSAR for HTS in vitro assays - a study for the prediction of Aryl hydrocarbon receptor activators
por: Abdelaziz, Ahmed M, et al.
Publicado: (2013)

Modeling selective attention using EEG data
por: Schrobsdorff, Hecke, et al.
Publicado: (2007)

P02.45. Description of naturopathic practice from clinical administrative data on 400,000 visits in academic clinics
por: Calabrese, C, et al.
Publicado: (2012)

DrugScorePPI for scoring protein-protein interactions: improving a knowledge-based scoring function by atomtype-based QSAR
por: Krüger, Dennis M, et al.
Publicado: (2010)

QSAR models reveal new EPAC-selective allosteric modulators
por: Mohamed, Hebatallah, et al.
Publicado: (2022)

Specific PKG inhibitors: do they really exist?
por: Gambaryan, Stepan, et al.
Publicado: (2011)

Circadian rhythm disruption exists in icu patients
por: Kiss, K, et al.
Publicado: (2015)

A unified approach to the applicability domain problem of QSAR models
por: Horvath, Dragos, et al.
Publicado: (2010)

Beyond descriptor vectors: QSAR modelling using structural similarity
por: Zell, Andreas, et al.
Publicado: (2008)

Network topology and intrinsic excitability of the existing network drive integration patterns in a model of adult neurogenesis
por: Roach, James P, et al.
Publicado: (2013)

Preliminary update of the Mortality Probability Model (MPM0)
por: Higgins, T, et al.
Publicado: (2005)

Patient selection guidelines for magnetic resonance focused ultrasound (MRgFUS) treatment: an updated view
por: Bryant, Kelli, et al.
Publicado: (2015)

The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods
por: Uceda, Julia, et al.
Publicado: (2012)

QSAR DataBank - an approach for the digital organization and archiving of QSAR model information
por: Ruusmann, Villu, et al.
Publicado: (2014)

Existence of interference between the heart and respiratory sounds: preliminary report
por: Finahari, N
Publicado: (2012)

Survey of the differences between Migraine and MOH pre-existing migraine
por: Igarashi, H
Publicado: (2013)

Optimizing existing health systems: an argument for integrating functioning information
por: Hopfe, Maren, et al.
Publicado: (2014)

Critical care outcomes in patients with pre-existing pulmonary hypertension
por: Bauchmuller, KB, et al.
Publicado: (2015)

Utilisation of existing community rehabilitation services by critical care survivors
por: Soulsby, CR, et al.
Publicado: (2015)

The borderline between cluster headache and migraine: does cluster-migraine exist?
por: Lisotto, C, et al.
Publicado: (2013)

Biotechnology: a non-existing word/world for the Brazilian deaf community
por: Mariani, Ruth, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l881ve57ditlefn5025v05l1ss